Proposed pathogenesis of inflammatory bowel disease and target sites for pharmacological intervention. Shown are the interactions among bacterial antigens.

Slides:



Advertisements
Similar presentations
Ahmad Shihada Silmi Hematologist & Immunologist IUG
Advertisements

Hannover Medical School February 15 th 2010 The gut microbiota shapes intestinal immune response during health and disease Round and Mazmanian, Nature.
The life history of T lymphocytes Precursors mature in the thymus Naïve CD4+ and CD8+ T cells enter the circulation Naïve T cells circulate through lymph.
Immunology of CELIAC DISEASE
SERUM CYTOKINE PATTERNS IN CELIAC DISEASE Shabab Naqvi & Ibrahim Ibrahim Mentor: Dr. Sanil Manavalan Columbia University, College of Physicians and Surgeons.
Effector T Cell Subsets, Cytokines
Environmental factors Dysregulated immune response
Immunity in the Gut Andrew M. Platt, University of Glasgow, UK
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
Cocaine-induced changes in CNS dopamine release
M1 – Immunology EFFECTOR T CELL FUNCTIONS (Part I) March 27, 2009 Ronald B. Smeltz, Ph.D. Microbiology and Immunology
Comparative success of therapy with proton pump inhibitors and H2 receptor antagonists. Data show the effects of a proton pump inhibitor (given once daily)
Sites of action of antifungal drugs
Proposed sites of action of current multiple sclerosis (MS) treatments
B. Major regulatory effects of ovarian steroids on hypothalamic-pituitary function. Estrogen decreases the amount of follicle-stimulating hormone (FSH)
B Cells: Regulatory (Bregs)
T cell differentiation
Experimental Models of Inflammatory Bowel Diseases
Chemical structure of eteplirsen (Drugbank Accession Number: DB06014);43 IUPAC chemical name: (P-deoxy-P-(dimethylamino)](2',3'-dideoxy-2',3'-imino-2',3'-seco)(2'a→5')(C-m5U-C-C-A-A-C-A-m5U-C-A-A-G-G-A-A-G-A-m5U-G-G-C-A-m5U-m5U-m5U-C-m5U-A-G),5'-(P-(4-((2
Structure and function of blinatumomab. A
Pathways regulating autophagy
Therapeutic injection site on the medial heel for plantar fasciitis
Testing the first MTP joint motion. (From Dutton M
Sites of action of hematopoietic growth factors in the differentiation and maturation of marrow cell lines. A self-sustaining pool of marrow stem cells.
Cardiovascular Risk and Psoriasis: Beyond the Traditional Risk Factors
Figure 2 Cell-mediated disease mechanisms of lupus nephritis
From: monocytes, macrophages and DCs
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
The role of viruses in acute exacerbations of asthma
Volume 57, Issue 1, Pages 6-8 (July 2012)
Figure 3 The T-cell cytokine tree in IBD
Microbial Influences in Inflammatory Bowel Diseases
The Th17 immune response in renal inflammation
Markers of cancer cell and lymphocytes in inflammatory infiltration around a tumour as potential markers of immunomodulatory treatment response. Markers.
Daniel A. Peterson, Daniel N. Frank, Norman R. Pace, Jeffrey I. Gordon 
Malaria Vaccine Design: Immunological Considerations
The Gastrointestinal Tract and AIDS Pathogenesis
Figure 1 Overview of the immunopathogenesis of ulcerative colitis
Benoit Chassaing, Arlette Darfeuille–Michaud  Gastroenterology 
INTERLEUKIN 10 (IL-10) CATEGORY: RECEPTORS & MOLECULES
ER stress-induced inflammation: does it aid or impede disease progression?  Abhishek D. Garg, Agnieszka Kaczmarek, Olga Krysko, Peter Vandenabeele, Dmitri.
Warren Strober, Ivan J. Fuss  Gastroenterology 
Figure 4 TNFSF inflammatory activities in tissue cells
Figure 3 Current model of immunopathogenesis in CIDP
Figure 3 Biologics that attenuate effector responses in the kidney
Celiac Disease: From Pathogenesis to Novel Therapies
John T. Chang, William J. Sandborn  Gastroenterology 
Mechanisms of Disease: Inflammatory Bowel Diseases
In Vivo Role of pDCs in Regulating Adaptive Immunity
Yasmine Belkaid, Guillaume Oldenhove  Immunity 
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Role of the Microbiota in Immunity and Inflammation
Translating Inflammatory Bowel Disease Research into Clinical Medicine
The Role of TIM-4 in Food Allergy
Volume 143, Issue 1, Pages (July 2012)
The gastrointestinal mucosa in health, CDI, and UC
Stefan H.E. Kaufmann, Shreemanta K. Parida  Cell Host & Microbe 
Interleukin-18 in Intestinal Inflammation: Friend and Foe?
Deciphering and Reversing Tumor Immune Suppression
Monocyte-Macrophages and T Cells in Atherosclerosis
Daniel A. Peterson, Daniel N. Frank, Norman R. Pace, Jeffrey I. Gordon 
A New “Immunological” Role for Adipocytes in Obesity
Lec.9 Cytokines.
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Basophils and mast cells in renal injury
Mechanisms of virus-induced airway inflammation in chronic obstructive pulmonary disease (COPD). Mechanisms of virus-induced airway inflammation in chronic.
The Biology of Intestinal Immunoglobulin A Responses
Learning Tolerance while Fighting Ignorance
Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases  Louis J. Cohen, Judy H. Cho,
Clara Abraham, Ruslan Medzhitov  Gastroenterology 
Presentation transcript:

Proposed pathogenesis of inflammatory bowel disease and target sites for pharmacological intervention. Shown are the interactions among bacterial antigens in the intestinal lumen and immune cells in the intestinal wall. If the epithelial barrier is impaired, bacterial antigens can gain access to antigen-presenting cells (APC) such as dendritic cells in the lamina propria. These cells then present the antigen(s) to CD4+ lymphocytes and also secrete cytokines such interleukin (IL)-12 and IL-18, thereby inducing the differentiation of TH1 cells in Crohn disease (or, under the control of IL-4, type 2 helper T cells [TH2] in ulcerative colitis). The balance of pro-inflammatory and anti-inflammatory events is also governed by regulatory TH17 and TReg cells, both of which serve to limit immune and inflammatory responses in the GI tract. Transforming growth factor (TGF)β and IL-6 are important cytokines that drive the expansion of the regulatory T cell subsets. The TH1 cells produce a characteristic array of cytokines, including interferon (IFN)γ and TNFα, which in turn activate macrophages. Macrophages positively regulate TH1 cells by secreting additional cytokines, including IFNγ and TNFα. Recruitment of a variety of leukocytes is mediated by activation of resident immune cells including neutrophils. Cell adhesion molecules such as integrins are important in the infiltration of leukocytes and novel biological therapeutic strategies aimed at blocking leukocyte recruitment are effective at reducing inflammation. General immunosuppressants (e.g., glucocorticoids, thioguanine derivatives, methotrexate, and cyclosporine) affect multiple sites of inflammation. More site-specific intervention involves intestinal bacteria (antibiotics, prebiotics, and probiotics) and therapy directed at TNFα or IL-12. (From Brunton LL, Chabner BA, Knollmann RC. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 12th ed. www.accessmedicine.com. Copyright © The McGraw-Hill Companies, Inc. All rights reserved.) Source: GASTROINTESTINAL DISORDERS, The Color Atlas of Physical Therapy Citation: Shamus E. The Color Atlas of Physical Therapy; 2015 Available at: http://accessphysiotherapy.mhmedical.com/DownloadImage.aspx?image=/data/books/1491/p9780071813518-ch041_f002.png&sec=90317035&BookID=1491&ChapterSecID=90316358&imagename= Accessed: October 31, 2017 Copyright © 2017 McGraw-Hill Education. All rights reserved